Intra-Cellular Therapies, Inc. (ITCI)
Data as of , from SEC Form 4 filings.
See up to 3 months of ITCI. The 7-day demo opens the 1M and 3M ranges and puts ITCI on your watchlist.
Start 7-day demoLatest ITCI insider trades
About Intra-Cellular Therapies, Inc. (ITCI)
Intra-Cellular Therapies, Inc. files with the SEC under CIK 0001567514 and is classified as pharmaceutical preparations. It is grouped with Health Care companies on this site.
ITCI Form 4 activity by transaction type, last 90 days
No Form 4 activity for ITCI in the last 90 days.
ITCI insider transactions (Form 4)
437 Form 4 filings on record, the earliest from Oct 2, 2024, newest first.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Nostrand Robert L. van | Derivative | Common Stock | 11,340 | $132.00 | $1.50M | |
| Nostrand Robert L. van | Derivative | Stock Option (right to buy) | 20,000 | - | - | |
| Nostrand Robert L. van | Derivative | Stock Option (right to buy) | 20,000 | - | - | |
| Nostrand Robert L. van | Derivative | Stock Option (right to buy) | 20,000 | - | - | |
| Nostrand Robert L. van | Derivative | Stock Option (right to buy) | 20,000 | - | - | |
| Nostrand Robert L. van | Derivative | Stock Option (right to buy) | 20,000 | - | - | |
| Nostrand Robert L. van | Derivative | Stock Option (right to buy) | 16,757 | - | - | |
| Nostrand Robert L. van | Derivative | Stock Option (right to buy) | 7,009 | - | - | |
| Nostrand Robert L. van | Derivative | Stock Option (right to buy) | 4,322 | - | - | |
| Nostrand Robert L. van | Derivative | Restricted Stock Units | 2,951 | - | - | |
| Joel S. Marcus | Derivative | Common Stock | 48,238 | $132.00 | $6.37M | |
| Joel S. Marcus | Derivative | Common Stock | 10,000 | $132.00 | $1.32M | |
| Joel S. Marcus | Derivative | Stock Option (right to buy) | 4,322 | - | - | |
| Joel S. Marcus | Derivative | Restricted Stock Units | 2,951 | - | - | |
| Rory B. Riggs | Derivative | Common Stock | 131,512 | $132.00 | $17.36M | |
| Rory B. Riggs | Derivative | Stock Option (right to buy) | 20,000 | - | - | |
| Rory B. Riggs | Derivative | Stock Option (right to buy) | 20,000 | - | - | |
| Rory B. Riggs | Derivative | Stock Option (right to buy) | 20,000 | - | - | |
| Rory B. Riggs | Derivative | Stock Option (right to buy) | 20,000 | - | - | |
| Rory B. Riggs | Derivative | Stock Option (right to buy) | 16,757 | - | - | |
| Rory B. Riggs | Derivative | Stock Option (right to buy) | 7,009 | - | - | |
| Rory B. Riggs | Derivative | Stock Option (right to buy) | 4,322 | - | - | |
| Rory B. Riggs | Derivative | Restricted Stock Units | 2,951 | - | - | |
| Sharon Mates - Officer | Option exercise | Common Stock | 51,000 | $12.73 | $649K | |
| Sharon Mates - Officer | Open-market sale | Common Stock | 27,667 | $85.62 | $2.37M | |
| Sharon Mates - Officer | Open-market sale | Common Stock | 23,333 | $86.00 | $2.01M | |
| Sharon Mates - Officer | Option exercise | Common Stock | 51,697 | $12.73 | $658K | |
| Sharon Mates - Officer | Open-market sale | Common Stock | 50,163 | $84.06 | $4.22M | |
| Sharon Mates - Officer | Open-market sale | Common Stock | 1,534 | $84.69 | $130K | |
| Sharon Mates - Officer | Option exercise | Stock Option (right to buy) | 51,000 | $0.00 | - | |
| Sharon Mates - Officer | Option exercise | Stock Option (right to buy) | 51,697 | $0.00 | - | |
| Michael Halstead - Officer | Option exercise | Common Stock | 22,869 | $23.94 | $547K | |
| Michael Halstead - Officer | Open-market sale | Common Stock | 15,105 | $88.72 | $1.34M | |
| Michael Halstead - Officer | Open-market sale | Common Stock | 6,116 | $89.63 | $548K | |
| Michael Halstead - Officer | Open-market sale | Common Stock | 1,648 | $90.89 | $150K | |
| Michael Halstead - Officer | Option exercise | Common Stock | 18,714 | $36.89 | $690K | |
| Michael Halstead - Officer | Open-market sale | Common Stock | 13,371 | $88.17 | $1.18M | |
| Michael Halstead - Officer | Open-market sale | Common Stock | 5,343 | $88.92 | $475K | |
| Michael Halstead - Officer | Option exercise | Stock Option (right to buy) | 22,869 | $0.00 | - | |
| Michael Halstead - Officer | Option exercise | Stock Option (right to buy) | 18,714 | $0.00 | - | |
| Rory B. Riggs | Option exercise | Common Stock | 14,189 | - | - | |
| Rory B. Riggs | Option exercise | Restricted Stock Units | 14,189 | $0.00 | - | |
| Rory B. Riggs | Grant or award | Common Stock | 246 | $73.17 | $18K |
ITCI insider trading FAQ
What is the latest insider trade for ITCI?
Intra-Cellular Therapies, Inc. (ITCI) has filed no insider reports in the last 90 days. The most recent on record is dated 2025-04-02. The full record for ITCI runs to 7 Form 4 filings, the earliest from 2024-10-02. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.
How many insiders are buying ITCI stock?
No insider purchases of ITCI were filed in the last 90 days.
How many insiders are selling ITCI stock?
No insider sales of ITCI were filed in the last 90 days. 9 sales are on record for this company.
Where can I see ITCI SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page collects ITCI Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Health Care companies with insider activity
Recent insider filings
7The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.
- - Nostrand Robert L. van view on EDGAR
- - Joel S. Marcus view on EDGAR
- - Rory B. Riggs view on EDGAR
- - Sharon Mates view on EDGAR
- - Michael Halstead view on EDGAR
- - Rory B. Riggs view on EDGAR
- - Rory B. Riggs view on EDGAR
Related companies with recent insider activity
Learn more
- What the Form 4 transaction codes mean
- Grants, option exercises, gifts and tax withholding are not trades on the market. The codes say which is which.
- Insider activity in Health Care
- Where ITCI's peers are being bought and sold.
- Every recent Form 4
- The market-wide feed, updated as filings arrive from SEC EDGAR.
Follow ITCI with a 7-day demo
- ITCI on your watchlist
- Every ITCI Form 4 filing on record
- Up to 3 months of ITCI price history
- The daily trading plan of ranked insider buys, on a delay, with the plan archive
